Date(s) - 27/09/2023
6:30 pm - 10:30 pm
LMU University Hospital Munich – A Medical Care Trailblazer
A story of medical technology leadership!
Speaker: Prof. Markus M. Lerch, CEO, LMU University Hospital Munich, Germany
When: Wednesday, 27 September (1830 – 2230)
Where: Marriott Hotel, Berliner Str. 93, 80505 Munich
Format: In-person meeting.
Costs: €30 for members, €40 for guests, €20 for students
Please get your ticket in advance from our ticket shop: https://american-german-business-club.sumupstore.com/
What a story of medical technology progress and success! While LMU Medicine can look back on a 550-year history, the LMU University Hospital in Munich was founded almost 200 years ago. Its history is highlighted by remarkable milestones in medicine – from the first surgical operation under anaesthesia to the first heart transplant in Germany.
With its leadership role in medical advances, LMU University Hospital is now one of Europe’s leading institutions for medical research, education, and patient care. With 2062 beds, 48 departments and institutes, 284 specialized outpatient clinics, and 50.000 surgical procedures, it is also one of the largest and most specialized university hospitals. In international rankings based on research output and grant acquisition, it ranks first in the nation, and most of its 197 professors are international leaders in their respective fields. A multi-billion program of the state of Bavaria will assure a state-of-the-art building infrastructure for the 21st century and significant investments into the Hospital’s medical innovation and environmental sustainability.
At the AGBC Munich’s 27 September monthly meeting, Professor Markus Lerch will lead the evening’s discussion on the vital role that LMU University Hospital performs in leading Munich, Bavarian, German and European medical advances.
Professor Lerch is a professor of medicine, physician in chief and CEO of LMU University Hospital in Munich. He attended Medical School in Freiburg, Glasgow, Toronto, and the University of Massachusetts. Then he received training in pathology, internal medicine, and gastroenterology at the universities of Freiburg, Aachen, and Ulm, and he held research positions at Harvard, the University of Milano, and the Max-Planck-Institute of Biochemistry in Martinsried/Munich. Before his present appointment, he was the professor of gastroenterology, endocrionology, and nutrition as well as chairman of the department of Medicine A and vice dean for research and clinical affairs at Greifswald University Hospital. His clinical and research interests are the pathophysiology, cell biology and genetics of pancreatic disorders. (https://orcid.org/0000-0002-9643-8263)